Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03222973 |
|---|---|
| Brief Title: | Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) (AFFINITY) |
| First Submitted : | July 17, 2017 |
| First Submitted that Met QC Criteria : | July 17, 2017 |
| First Posted : | July 19, 2017 |
| Last Update Submitted that Met QC Criteria : | September 24, 2020 |
| Last Update Posted : | September 25, 2020 |